Prudential Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,495
| Closed | -$202K | – | 2525 |
|
|
2025
Q1 | $202K | Hold |
2,495
| – | – | ﹤0.01% | 2074 |
|
|
2024
Q4 | $225K | Sell |
2,495
-22,153
| -90% | -$2M | ﹤0.01% | 2062 |
|
|
2024
Q3 | $2.44M | Buy |
24,648
+244
| +1% | +$24.1K | ﹤0.01% | 1383 |
|
|
2024
Q2 | $2.26M | Buy |
24,404
+4,963
| +26% | +$460K | ﹤0.01% | 1356 |
|
|
2024
Q1 | $1.84M | Buy |
19,441
+323
| +2% | +$30.7K | ﹤0.01% | 1499 |
|
|
2023
Q4 | $1.71M | Buy |
19,118
+1,257
| +7% | +$112K | ﹤0.01% | 1533 |
|
|
2023
Q3 | $1.3M | Sell |
17,861
-265
| -1% | -$19.4K | ﹤0.01% | 1631 |
|
|
2023
Q2 | $1.51M | Buy |
18,126
+2,302
| +15% | +$192K | ﹤0.01% | 1592 |
|
|
2023
Q1 | $1.21M | Buy |
15,824
+1,790
| +13% | +$136K | ﹤0.01% | 1639 |
|
|
2022
Q4 | $1.16M | Sell |
14,034
-279
| -2% | -$23.2K | ﹤0.01% | 1624 |
|
|
2022
Q3 | $1.13M | Sell |
14,313
-1,377
| -9% | -$109K | ﹤0.01% | 1691 |
|
|
2022
Q2 | $1.17M | Buy |
15,690
+2,683
| +21% | +$201K | ﹤0.01% | 1704 |
|
|
2022
Q1 | $1.17M | Buy |
13,007
+2,449
| +23% | +$220K | ﹤0.01% | 1808 |
|
|
2021
Q4 | $1.41M | Sell |
10,558
-551
| -5% | -$73.4K | ﹤0.01% | 1717 |
|
|
2021
Q3 | $1.48M | Sell |
11,109
-1,196
| -10% | -$159K | ﹤0.01% | 1616 |
|
|
2021
Q2 | $1.67M | Buy |
12,305
+1,598
| +15% | +$216K | ﹤0.01% | 1567 |
|
|
2021
Q1 | $1.45M | Buy |
10,707
+4,278
| +67% | +$581K | ﹤0.01% | 1637 |
|
|
2020
Q4 | $905K | Buy |
6,429
+823
| +15% | +$116K | ﹤0.01% | 1799 |
|
|
2020
Q3 | $624K | Buy |
5,606
+2,382
| +74% | +$265K | ﹤0.01% | 1871 |
|
|
2020
Q2 | $361K | Buy |
3,224
+124
| +4% | +$13.9K | ﹤0.01% | 2044 |
|
|
2020
Q1 | $240K | Buy |
+3,100
| New | +$240K | ﹤0.01% | 2131 |
|